Publicité
La bourse est fermée
  • CAC 40

    7 479,40
    -51,32 (-0,68 %)
     
  • Euro Stoxx 50

    4 894,02
    -8,58 (-0,18 %)
     
  • Dow Jones

    39 118,86
    -45,24 (-0,12 %)
     
  • EUR/USD

    1,0742
    +0,0033 (+0,31 %)
     
  • Gold future

    2 336,90
    -2,70 (-0,12 %)
     
  • Bitcoin EUR

    57 535,70
    +796,76 (+1,40 %)
     
  • CMC Crypto 200

    1 287,30
    +3,47 (+0,27 %)
     
  • Pétrole WTI

    81,46
    -0,08 (-0,10 %)
     
  • DAX

    18 235,45
    +24,85 (+0,14 %)
     
  • FTSE 100

    8 164,12
    -15,56 (-0,19 %)
     
  • Nasdaq

    17 732,60
    -126,10 (-0,71 %)
     
  • S&P 500

    5 460,48
    -22,39 (-0,41 %)
     
  • Nikkei 225

    39 583,08
    +241,58 (+0,61 %)
     
  • HANG SENG

    17 718,61
    +2,11 (+0,01 %)
     
  • GBP/USD

    1,2649
    +0,0008 (+0,06 %)
     

PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble

PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble

European regulators rejected PTC Therapeutics' Duchenne muscular dystrophy drug — again — sending PTC stock into free fall early Friday.